Search clinical trials for: Acalabrutinib ( /- Obinutuzumab)
Total 427 results
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaArgentina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingObinutuzumab | Rapid Infusion | Intravenous Infusion ReactionChina
-
iOMEDICO AGAstraZenecaRecruiting
-
Ruijin HospitalRecruitingFollicular LymphomaChina
-
Polish Lymphoma Research GroupRoche Pharma AGTerminatedMantle Cell LymphomaPoland
-
Qianfoshan HospitalNot yet recruitingIdiopathic Membranous Nephropathy
-
Institute of Hematology & Blood Diseases Hospital...RecruitingB Cell LymphomaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingMarginal Zone LymphomaChina
-
Healthy FutureRecruiting
-
Klinikum StuttgartUniversity Hospital FreiburgTerminatedPrimary CNS LymphomaGermany
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Dalian Medical UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
University of California, San DiegoGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingSteroid-Dependent Nephrotic Syndrome | Steroid-Sensitive Nephrotic SyndromeFrance
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid TissueFrance
-
Institute of Hematology & Blood Diseases Hospital...RecruitingImmune Thrombocytopenia | TreatmentChina
-
University of Wisconsin, MadisonGenentech, Inc.TerminatedMantle Cell Lymphoma | Non Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
Institute of Hematology & Blood Diseases HospitalRecruitingImmune Thrombocytopenia | TreatmentChina
-
French Innovative Leukemia OrganisationHoffmann-La RocheRecruiting
-
Mayo ClinicGenentech, Inc.Active, not recruiting
-
Hoffmann-La RocheCompletedFollicular Lymphoma | Chronic Lymphocytic LeukemiaKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGRecruitingLupus Nephritis | Systemic Lupus Erythematosus (SLE)France
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; BeiGene USA, Inc.; Roche-GenentechRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
Christian BuskeRoche Pharma AG; University of Ulm; Zentrum für Klinische Studien Ulm; X-act Cologne... and other collaboratorsActive, not recruiting
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
Massachusetts General HospitalGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Incyte CorporationWithdrawnMarginal Zone Lymphoma (MZL) | Follicular Lymphoma ( FL)
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGRecruiting
-
Mario Negri Institute for Pharmacological ResearchRoche Pharma AGActive, not recruiting
-
Heidelberg UniversityRoche Pharma AGActive, not recruitingStage II Grade 1 Follicular Lymphoma | Stage II Grade 2 Follicular Lymphoma | Stage I Follicular Lymphoma Grade 1 | Stage II Follicular Lymphoma Grade 2Germany
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
Fondazione Italiana Linfomi - ETSTerminatedFollicular LymphomaItaly
-
Paolo GhiaRecruitingChronic Lymphocytic LeukemiaItaly
-
Polish Myeloma ConsortiumRoche Pharma AG; Bioscience, S.A.UnknownWaldenstrom MacroglobulinemiaPoland
-
Bnai Zion Medical CenterTel-Aviv Sourasky Medical CenterRecruiting
-
Deok-Hwan YangRoche Pharma AGUnknown
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
University of UlmAbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study GroupCompletedLeukemia, Lymphocytic, ChronicGermany
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Case Comprehensive Cancer CenterGenentech, Inc.WithdrawnSingle Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)Post-transplant Lymphoproliferative Disorder | PTLD
-
Prof. Dr. Wolfgang HiddemannHoffmann-La Roche; Mundipharma Research GmbH & Co KGCompleted
-
Abramson Cancer Center at Penn MedicineGenentech, Inc.RecruitingDLBCL - Diffuse Large B Cell Lymphoma | Large B-cell LymphomaUnited States
-
Niguarda HospitalRecruitingCLL TransformationItaly, Switzerland
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); AstraZeneca; Genentech, Inc.; National Institutes...Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
German CLL Study GroupAstraZenecaRecruiting